摘要
Wolcott-Rallison综合征(WRS)以永久性新生儿糖尿病、多发性骨骺发育不良为主要临床表现,致病基因为编码真核生物翻译起始因子2a激酶3的基因。WRS综合征发病率极低,预后欠佳,患儿多于幼年死亡。本文就WRS综合征的遗传发病机制及诊疗进展进行综述,以提高临床医师对本病的认识。
Wolcott-Rallison syndrome is associated with permanent skeletal dysplasia and caused by mutations in the gene encoding eukaryotic neonatal diabetes mellitus and translation initiation factor 2a kinase 3 (EIF2AK3). Prognosis is poor and most patients die at a young age. The article aims at enhancing the consciousness of clinical doctors on finding WRS and improving the prognosis of such patients.
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2014年第5期469-470,共2页
Chinese Journal of Diabetes
基金
北京市卫生系统高层次卫生技术人才培养计划(2011-3-051)